Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Muldoon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Neuro-Oncology|November 30, 2005
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomasWalter A Hall, Nancy D Doolittle, Megan Daman, et al.
Neuro-Oncology Practice|May 23, 2022
[<sup>18</sup>F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumabRamon F Barajas, Prakash Ambady, Jeanne Link, et al.
Annals of Surgical Oncology|October 20, 2009
Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cellsSuEllen J Pommier, Glenda G Quan, Dara Christante, et al.
Neuro-Oncology|April 8, 2015
Unsanctifying the sanctuary: challenges and opportunities with brain metastasesShannon Puhalla, William Elmquist, David Freyer, et al.
Cancer Therapy|December 17, 2008
siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic StimuliRichard Tritz, Barbara M Mueller, Michelle J Hickey, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Neuro-Oncology|November 30, 2005
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomasWalter A Hall, Nancy D Doolittle, Megan Daman, et al.
Neuro-Oncology Practice|May 23, 2022
[<sup>18</sup>F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumabRamon F Barajas, Prakash Ambady, Jeanne Link, et al.
Annals of Surgical Oncology|October 20, 2009
Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cellsSuEllen J Pommier, Glenda G Quan, Dara Christante, et al.
Neuro-Oncology|April 8, 2015
Unsanctifying the sanctuary: challenges and opportunities with brain metastasesShannon Puhalla, William Elmquist, David Freyer, et al.
Cancer Therapy|December 17, 2008
siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic StimuliRichard Tritz, Barbara M Mueller, Michelle J Hickey, et al.
Pageof 1